Skip to content

STREAMLINE HEALTH SOLUTIONS INC.: 10-Q filed 2018-06-13

What STREAMLINE HEALTH SOLUTIONS INC. reported in its quarterly report filed 2018-06-13 (fiscal Q1 2018): 34 published measures, 71 facts as tagged in accession 0001628280-18-007833.

This filing

Form
10-Q (quarterly report)
Filed
2018-06-13
Fiscal period
fiscal Q1 2018
Accession
0001628280-18-007833 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All STREAMLINE HEALTH SOLUTIONS INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2018-04-3037,311,291USD
At 2018-01-3137,131,054USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2018-04-3017,562,902USD
At 2018-01-3118,429,468USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2018-04-3011,061,997USD
At 2018-01-319,851,601USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2018-04-303,745,532USD
At 2018-01-314,619,834USD
At 2017-04-303,577,245USD
At 2017-01-315,654,093USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2018-02-01 to 2018-04-30-568,699USD89
2017-02-01 to 2017-04-30-2,042,508USD89

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2018-02-01 to 2018-04-3036,970USD89
2017-02-01 to 2017-04-30-1,454,942USD89

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2018-02-01 to 2018-04-303,300USD89
2017-02-01 to 2017-04-308,719USD89

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2018-02-01 to 2018-04-30-196,150USD89
2017-02-01 to 2017-04-30-226,689USD89

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2018-02-01 to 2018-04-30-715,122USD89
2017-02-01 to 2017-04-30-395,217USD89

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2018-04-30-71,253,816USD
At 2018-02-01-70,685,000USD
At 2018-01-31-72,125,065USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2018-02-01 to 2018-04-3019,986,425shares89
2017-02-01 to 2017-04-3019,695,390shares89

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2018-02-01 to 2018-04-3019,986,425shares89
2017-02-01 to 2017-04-3019,695,390shares89

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2018-02-01 to 2018-04-30-0.03USD/shares89
2017-02-01 to 2017-04-30-0.1USD/shares89

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2018-02-01 to 2018-04-30-0.03USD/shares89
2017-02-01 to 2017-04-30-0.1USD/shares89

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2018-02-01 to 2018-04-301,714USD89
2017-02-01 to 2017-04-302,608USD89

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2018-04-30993,454USD
At 2018-01-311,162,364USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2018-02-01 to 2018-04-30222,458USD89
2017-02-01 to 2017-04-30267,174USD89

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2018-02-01 to 2018-04-30-363,122USD89
2017-02-01 to 2017-04-30-1,874,588USD89

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2018-04-309,198,138USD
At 2018-01-319,646,681USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2018-02-01 to 2018-04-30116,218USD89
2017-02-01 to 2017-04-30127,268USD89

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2018-04-3010,838,184USD
At 2018-01-3111,452,149USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2018-04-301,344,377USD
At 2018-01-31421,425USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2018-04-3015,537,281USD
At 2018-01-3115,537,281USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2018-04-302,819,849USD
At 2018-01-313,001,170USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2018-02-01 to 2018-04-303,249,057USD89
2017-02-01 to 2017-04-303,373,528USD89

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2018-02-01 to 2018-04-301,062,319USD89
2017-02-01 to 2017-04-301,556,938USD89

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2018-04-3020,034,446shares
At 2018-01-3120,005,977shares

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2018-04-304,974,765USD
At 2018-01-314,996,517USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2018-04-303,981,311USD
At 2018-01-313,834,153USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2018-04-305,600,204USD
At 2018-01-315,835,151USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2018-02-01 to 2018-04-30171,215USD89
2017-02-01 to 2017-04-30202,782USD89

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2018-02-01 to 2018-04-30234,947USD89
2017-02-01 to 2017-04-30333,057USD89

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2018-02-01 to 2018-04-30-87,645USD89
2017-02-01 to 2017-04-30-38,044USD89

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2018-02-01 to 2018-04-30922,952USD89
2017-02-01 to 2017-04-30-240,403USD89

Inspect the source

Entity
STREAMLINE HEALTH SOLUTIONS INC. / CIK 0001008586
Captured
2026-09-21T17:17:56.440Z
SEC response SHA-256
f28ec2b62f459f9e1502e7518fb1b41cf9eab0c85e2282d838d54aa5e44579c9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001008586.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))